Mefloquine for preventing malaria in pregnant women
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Mefloquine for Preventing Malaria in Pregnant Women." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435282/all/Mefloquine_for_preventing_malaria_in_pregnant_women.
Mefloquine for preventing malaria in pregnant women. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435282/all/Mefloquine_for_preventing_malaria_in_pregnant_women. Accessed November 22, 2024.
Mefloquine for preventing malaria in pregnant women. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435282/all/Mefloquine_for_preventing_malaria_in_pregnant_women
Mefloquine for Preventing Malaria in Pregnant Women [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435282/all/Mefloquine_for_preventing_malaria_in_pregnant_women.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mefloquine for preventing malaria in pregnant women
ID - 435282
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435282/all/Mefloquine_for_preventing_malaria_in_pregnant_women
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -